Extracts of Cerbera manghas L. effectively inhibit the viability of glioblastoma cell lines and their cancer stemloids in vitro and in mouse xenograft model

Jui Cheng Tsai, Wen Shan Liu, Ying Ting Tseng, Hoi Ian Lam, Szu Ying Chen, Cheng Li Fang, Tien Soung Tong, Yun Ju Lai

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Glioblastoma multiforme (GBM), a highly recurrent malignant disease, is a grade IV glioma with poor prognosis. Glioblastoma stem cells (GSCs) are the new potential target for GBM intervention. To develop an improved treatment by targeting GSCs, we identified neriifolin, an active principle in extracts of Cerbera manghas L., as an effective inhibitor for the growth and migration of GBM cell lines and their tumorspheres. In this study, neriifolin effectively inhibited the growth and colony formation of CD133+ GBM tumorspheres. Both C. manghas extracts and neriifolin inhibited Akt activation and caused cell cycle G1 arrest. They also reduced the expression of the stem cell marker Sox2. Treatment with their higher doses induced the apoptosis of GBM tumorspheres. Furthermore, neriifolin inhibited the growth of CD133+ GBM tumorsphere-derived tumors in vivo. In summary, neriifolin obtained from extracts of C. manghas may serve as a drug lead compound for GBM therapies.

Original languageEnglish
Pages (from-to)283-296
Number of pages14
JournalJournal of Functional Foods
Volume48
DOIs
Publication statusPublished - 2018 Sep 1

Fingerprint

Apocynaceae
Glioblastoma
Heterografts
stem cells
animal models
cell lines
viability
Cell Line
neoplasms
extracts
Neoplasms
prognosis
cell cycle
Stem Cells
apoptosis
drugs
therapeutics
dosage
G1 Phase Cell Cycle Checkpoints
In Vitro Techniques

Keywords

  • Cancer stem cell
  • Glioblastoma
  • Herbal extracts
  • Neriifolin

ASJC Scopus subject areas

  • Food Science
  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Extracts of Cerbera manghas L. effectively inhibit the viability of glioblastoma cell lines and their cancer stemloids in vitro and in mouse xenograft model. / Tsai, Jui Cheng; Liu, Wen Shan; Tseng, Ying Ting; Lam, Hoi Ian; Chen, Szu Ying; Fang, Cheng Li; Tong, Tien Soung; Lai, Yun Ju.

In: Journal of Functional Foods, Vol. 48, 01.09.2018, p. 283-296.

Research output: Contribution to journalArticle

Tsai, Jui Cheng ; Liu, Wen Shan ; Tseng, Ying Ting ; Lam, Hoi Ian ; Chen, Szu Ying ; Fang, Cheng Li ; Tong, Tien Soung ; Lai, Yun Ju. / Extracts of Cerbera manghas L. effectively inhibit the viability of glioblastoma cell lines and their cancer stemloids in vitro and in mouse xenograft model. In: Journal of Functional Foods. 2018 ; Vol. 48. pp. 283-296.
@article{2a55b2a411c142bdb57b1af8fb04d320,
title = "Extracts of Cerbera manghas L. effectively inhibit the viability of glioblastoma cell lines and their cancer stemloids in vitro and in mouse xenograft model",
abstract = "Glioblastoma multiforme (GBM), a highly recurrent malignant disease, is a grade IV glioma with poor prognosis. Glioblastoma stem cells (GSCs) are the new potential target for GBM intervention. To develop an improved treatment by targeting GSCs, we identified neriifolin, an active principle in extracts of Cerbera manghas L., as an effective inhibitor for the growth and migration of GBM cell lines and their tumorspheres. In this study, neriifolin effectively inhibited the growth and colony formation of CD133+ GBM tumorspheres. Both C. manghas extracts and neriifolin inhibited Akt activation and caused cell cycle G1 arrest. They also reduced the expression of the stem cell marker Sox2. Treatment with their higher doses induced the apoptosis of GBM tumorspheres. Furthermore, neriifolin inhibited the growth of CD133+ GBM tumorsphere-derived tumors in vivo. In summary, neriifolin obtained from extracts of C. manghas may serve as a drug lead compound for GBM therapies.",
keywords = "Cancer stem cell, Glioblastoma, Herbal extracts, Neriifolin",
author = "Tsai, {Jui Cheng} and Liu, {Wen Shan} and Tseng, {Ying Ting} and Lam, {Hoi Ian} and Chen, {Szu Ying} and Fang, {Cheng Li} and Tong, {Tien Soung} and Lai, {Yun Ju}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.jff.2018.07.017",
language = "English",
volume = "48",
pages = "283--296",
journal = "Journal of Functional Foods",
issn = "1756-4646",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Extracts of Cerbera manghas L. effectively inhibit the viability of glioblastoma cell lines and their cancer stemloids in vitro and in mouse xenograft model

AU - Tsai, Jui Cheng

AU - Liu, Wen Shan

AU - Tseng, Ying Ting

AU - Lam, Hoi Ian

AU - Chen, Szu Ying

AU - Fang, Cheng Li

AU - Tong, Tien Soung

AU - Lai, Yun Ju

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Glioblastoma multiforme (GBM), a highly recurrent malignant disease, is a grade IV glioma with poor prognosis. Glioblastoma stem cells (GSCs) are the new potential target for GBM intervention. To develop an improved treatment by targeting GSCs, we identified neriifolin, an active principle in extracts of Cerbera manghas L., as an effective inhibitor for the growth and migration of GBM cell lines and their tumorspheres. In this study, neriifolin effectively inhibited the growth and colony formation of CD133+ GBM tumorspheres. Both C. manghas extracts and neriifolin inhibited Akt activation and caused cell cycle G1 arrest. They also reduced the expression of the stem cell marker Sox2. Treatment with their higher doses induced the apoptosis of GBM tumorspheres. Furthermore, neriifolin inhibited the growth of CD133+ GBM tumorsphere-derived tumors in vivo. In summary, neriifolin obtained from extracts of C. manghas may serve as a drug lead compound for GBM therapies.

AB - Glioblastoma multiforme (GBM), a highly recurrent malignant disease, is a grade IV glioma with poor prognosis. Glioblastoma stem cells (GSCs) are the new potential target for GBM intervention. To develop an improved treatment by targeting GSCs, we identified neriifolin, an active principle in extracts of Cerbera manghas L., as an effective inhibitor for the growth and migration of GBM cell lines and their tumorspheres. In this study, neriifolin effectively inhibited the growth and colony formation of CD133+ GBM tumorspheres. Both C. manghas extracts and neriifolin inhibited Akt activation and caused cell cycle G1 arrest. They also reduced the expression of the stem cell marker Sox2. Treatment with their higher doses induced the apoptosis of GBM tumorspheres. Furthermore, neriifolin inhibited the growth of CD133+ GBM tumorsphere-derived tumors in vivo. In summary, neriifolin obtained from extracts of C. manghas may serve as a drug lead compound for GBM therapies.

KW - Cancer stem cell

KW - Glioblastoma

KW - Herbal extracts

KW - Neriifolin

UR - http://www.scopus.com/inward/record.url?scp=85049792445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049792445&partnerID=8YFLogxK

U2 - 10.1016/j.jff.2018.07.017

DO - 10.1016/j.jff.2018.07.017

M3 - Article

AN - SCOPUS:85049792445

VL - 48

SP - 283

EP - 296

JO - Journal of Functional Foods

JF - Journal of Functional Foods

SN - 1756-4646

ER -